Introduction
The hepatitis E virus (HEV) is a major pathogen causing acute hepatitis in young people in developing countries where there is poor sanitation and a high population density. HEV infection is often asymptomatic but can induce a self-limited acute hepatitis. 1 Hepatitis E has been diagnosed in industrialized countries, and it has been demonstrated that the genomic sequence of isolated HEV strains is most related to swine HEV prevalent in the swine population from the same region. 2 The existence of a zoonotic reservoir has also been revealed, as the virus has been isolated from wild and domestic animals including swine, cattle, chickens, sheep, goats, and rodents. 3, 4 The first animal virus strain was isolated from a pig in the USA. 5 Interspecific infections with hepatitis E among pigs and non-human primates have been demonstrated experimentally, suggesting the zoonotic nature of the disease. 6 Human and swine HEV are classified in the Hepeviridae family as a separate Orthohepevirus genus Orthohepevirus A species. 7 Like most enteric viruses, HEV is a relatively stable particle, resistant to gastric secretions and bile salts, which explains its survival in the intestinal environment. 8 It is a small virus with a diameter between 27 and 33 nm, with an icosahedral structure without an envelope, which has shaped bumps visible on its surface. 9 The genome is represented by a single-stranded positive-sense RNA molecule of 7.2 kb in length, which contains three open reading frames (ORF). 10 Four major genotypes have been defined in mammals based on ORF2 nucleotide sequence analysis. 11 The four genotypes are classified into 24 subtypes, based on a sequence located at the 5 0 end of the ORF2 region, which is the best conserved among all HEV isolates.
12 Genotypes 1 and 2 do not infect swine, while genotypes 3 and 4 are zoonotic. 13 The natural transmission of swine HEV in pigs is via the faecal-oral route. HEV infection in swine usually remains asymptomatic. HEV replication has been demonstrated to occur in the liver and in the intestines.
14 Viraemia is transient and lasts distribution of HEV infection in pigs, and the prevalence varies from 15% to 75%. [16] [17] [18] In Europe, HEV has been detected in swine in several countries; the isolated swine HEV has been characterized as genotype 3 19 and 4. 20 In Spain, HEV RNA detected in slaughterhouse sewage presented 92-94% nucleotide similarity with virus strains detected in humans. 21 The prevalence of swine HEV in France was estimated at 31% at the individual pig level and 65% at the farm level. 22 In the Netherlands, 97 pig farms were screened in 2005 and the prevalence rate of swine HEV was estimated at 55%. 23 Investigations of domestic swine in Hungary detected HEV in 39% of the pig farms involved. 24 The purpose of this investigation was to assess the HEV seroprevalence in human samples and to detect the presence of swine HEV RNA in farm pigs from Romania, with genetic characterization and phylogenetic analysis.
Materials and methods

Sample collection
Human serum from anonymous donors was provided by hospitals in the North-eastern Region of Romania. The donors were undergoing routine haematological tests and had no hepatitis symptomatology. Serum from a total of 148 people aged between 10 and 90 years was evaluated between 2011 and 2012.
Pig stool samples (n = 19) were collected from five swine farms in the eastern part of Romania in 2009 and 2010. Faecal pools were sampled from shelters where the 2-to 4-month-old pigs were housed. All samples were transported at refrigeration temperature and stored at À80 8C until testing.
Anti-HEV serology
Tests for anti-HEV immunoglobulin (Ig) G were performed using a commercial ELISA kit (MP Biomedicals; catalogue number 0721150096T) in accordance with the manufacturer's instructions. This assay uses three recombinant polypeptides derived from the 3 0 end of ORF2 (42 amino acids) and ORF3 (33 amino acids) from Burmese and Mexican prototype sequences (genotypes 1 and 2, respectively). For each determination, positive and negative controls, provided with the kit, were used. The cut-off value was calculated as 0.500 plus the mean absorbance of the non-reactive controls. IgG-reactive samples were retested using the same commercial kit.
Processing of stool samples
Pooled samples were resuspended in 10% calcium-and magnesium-free phosphate-buffered saline and centrifuged at 3000 rpm.
RNA extraction and nested RT-PCR
The RNA extraction was performed from 200 ml stool suspension supernatant using the QIAamp Viral RNA Mini Kit (Qiagen; catalogue number 52904). The extracted RNAs were stored at À80 8C until tested. Reverse transcription was performed using a random hexamer primer (Promega; catalogue number C1181).
For the detection of HEV RNA, a nested RT-PCR was performed using the degenerate primers. 13 All samples were tested for HEV RNA, targeting an ORF2 348-bp fragment. For the nested RT-PCR assay, two sets of primers were used: external primer set 3156N (5663 to 5684) and 3157N (6371 to 6393), and internal primer set 3158N (5948 to 5969) and 3159N (6274 to 6295). Negative and positive controls were included in each set of PCRs. Negative control (ultrapure water) was included in every reverse transcription, first PCR, and nested PCR. An extract from a positive HEV genotype 3 swine faecal sample was used as positive control.
The PCR parameters for the first-round PCR with primers 3156N and 3157N included a denaturation step at 94 8C for 1 min, followed by 30 cycles of denaturation for 30 s at 94 8C, annealing for 30 s at 52 8C, extension for 30 s at 72 8C, and 10 cycles of denaturation for 30 s at 94 8C, annealing for 30 s at 40 8C, extension for 30 s at 72 8C, followed by a final incubation at 72 8C for 5 min.
At the end of the first-round PCR, 5 ml of the amplification product and an internal primer set were used to prepare a 50-ml reaction mix for the second-round PCR. Ten microlitres of DNA were analysed by agarose gel electrophoresis.
Nucleotide sequencing and sequence analyses
The amplified 348-bp fragments were excised from the gel and purified using the Wizard SV Gel and PCR Clean-Up System (Promega; catalogue number A9281). The purified products were directly sequenced for both strands with nested PCR primers using the CEQ 8000 Genetic Analysis System and dye-labelled dideoxy termination method (DTCS QuickStart sequencing reagent; Beckman Coulter, Fullerton, CA, USA).
Individual sequences were proofread and edited using CEQ 8000 software (Beckman Coulter), and merged into composite sequences with SeqMan software (Lasergene v. 7; DNASTAR Inc., Madison, WI, USA). Different sequences were used to root the phylogeny and were chosen as the best hits to our sequences in GenBank. Phylogenetic inference was conducted for the combined concatenated dataset. jModelTest version 2.0 25 was used to infer the best-fit model of evolution, based on hierarchical loglikelihood ratio tests comparing successively complex models. The evolutionary history was inferred using the maximum likelihood method based on the generalized time-reversible model (GTR+G). The tree topology search was done using the Best of NNIs and SPRs algorithm, over 100 bootstrapped replications of the dataset. The analysis involved 260 nucleotide sequences. Evolutionary analyses were conducted in PhyML v3.0, 26 run on the Phylemon 2.0 platform. 27 
Results
Serological results
Out of 148 human sera tested, 22 were positive for anti-HEV IgG. In sera analysed in 2011 (first study) a 17.14% seroprevalence (12/70) was estimated, whereas in 2012 (second study) a 12.82% seroprevalence (10/78) was recorded (Tables 1-3 ). Anti-HEV IgG antibody in subjects without clinical signs of hepatitis was used as an epidemiological tool to measure exposure to this virus. Our results revealed that HEV infections in the eastern area of Romania affect middle-aged adults.
Swine HEV detection
Faecal samples (19 pools) collected from five swine farms with pigs aged between 2 and 4 months were subsequently analysed by RT-PCR to detect the presence of HEV. The analysis of nested PCR products revealed six positive stool samples ( Table 4) . The virus was detected in pooled samples collected from pigs of different ages: 2.5 months old (farms B and E), 3 months old (farms C and A), and 4 months old (farm D). To characterize the viral strains circulating in the farm-pig populations, two of the positive PCR products were sequenced and analysed. A 347-nucleotide sequence (roEF5; GenBank accession number KM058114) and a 341-nucleotide sequence (roFPR4, GenBank accession number KM042904) were obtained.
Phylogenetic analysis
The two Romanian sequences were found to be distributed in different clades. According to the nucleotide sequence similarities analysis there was a 16.2% difference between the two newly identified swine HEV sequences.
Discussion
Autochthonous HEV infection, caused by genotype 3, is recognized as an emerging infectious disease in developed countries. Our previous investigation on HEV infection in eastern Romania revealed an anti-HEV IgG prevalence of 12% (3/25) in patients diagnosed with hepatitis B or C, 28 and a 5.9% anti-HEV IgG seroprevalence (4/67) in the general population. 29 In 2010, Voiculescu et al. reported an HEV seroprevalence of 12.5% in the very low risk population and 13.98% in the low risk population. 30 In this study the presence of anti-HEV IgG was evaluated in 148 anonymous donors aged between 10 and 90 years. Eleven serum samples collected from children and adolescent patients (9-20 years old) were identified as negative for anti-HEV IgG. All infections seem to occur among middle-aged persons. These observations agree with the data recorded from patients with locally acquired hepatitis E in non-endemic countries. 31 The HEV antigens used in this kit included an ORF3 antigen, making it possible to detect a class of IgG antibody that is present early in infection. 32 The commercially available anti-HEV ELISA test (MP Biomedicals) uses antigens derived from genotypes 1 and 2 of HEV and may underestimate the HEV seroprevalence in non-endemic regions where genotype 3 HEV is the most prevalent. In various studies, the IgG antibodies have proved to persist for 2-13 years. 33 The results of studies done in developed countries have shown that seropositivity increases in linear proportion with increasing age. In certain developed countries, the seroprevalence of anti-HEV IgG in the general population has been shown to be generally much higher than would be expected given the low prevalence of acute symptomatic hepatitis E cases. The prevalence of anti-HEV in human populations suggests the possibility of subclinical HEV infections and/or under-diagnosis. Autochthonous hepatitis E in developed regions is frequently misdiagnosed as drug-induced liver injury, a common problem that occurs at an increased frequency in elderly people. 34 The prevalence of HEV IgG antibodies in low-incidence populations in the developed world ranges from 3.2% in central France, 35 4.9% in southwest Switzerland, 36 and 16% in southwest England, 31 to 21% in residents of the USA. 37 In Spain, the prevalence of IgG antibodies against HEV, which indicates exposure to this virus, varies from 0.6% to 7.3% in the general population, reaching 19% in individuals with risk factors such as exposure to pigs. 38 Our results on random serum samples demonstrated an overall seropositivity of 14.86%. The age-dependent seroprevalence could only be explained by agedependent exposure or age-dependent susceptibility, which is difficult to consider for a food-borne pathogen. 39 It has been reported that a large proportion of pigs are infected with HEV in the world. Our previous investigations regarding swine HEV infection in Romania consisted of serological testing for the detection of anti-HEV IgG in farm and backyard pigs. The immunoblot results of our investigations of farm pigs revealed 37 anti-HEV IgG-positive serum samples out of 95 tested (38.94%). 40 For the backyard pigs, we detected 34 positive serum samples out of 69 (49.27%) tested by immunoblot. 29 In this study, two swine HEV strains isolated from farm pigs in Romania were characterized. To our knowledge, this is the first study to confirm the presence of swine HEV in Romania. All faecal samples were collected from swine without clinical symptoms. Swine HEV RNA was isolated from faecal samples collected from 2-to 4-month-old pigs. These results are similar to previously published data, confirming that HEV is circulating in all farms and in all age groups, from weaners to fatteners, and that pigs that are close to slaughter age can still be HEV-infected. 41 Romanian swine HEV isolates were grouped into genotype 3 by phylogenetic tree analysis and were closely related to the swine and human HEV isolates identified in European countries. Analysis of the sequences (Fig. 1) revealed that, at the amino acid level, the partial capsid protein sequence (ORF2) of strain roEF5 presented a maximum 92% identity with a French human isolate (GenBank accession number EU495231) and 89% identity with a swine HEV isolate from wild boar in Germany (GenBank accession number KF303501.1), a French human strain (GenBank accession number GQ427014), and a human strain isolated in Italy (GenBank accession number HM446630.1). Phylogenetic analysis revealed that this swine HEV had 91% identity with six swine strains isolated in Bolivia (GenBank accession numbers JQ424439.1, JQ424440.1, JQ424437.1, JQ424442.1, JQ424441.1, and JQ424438.1) and 90% identity with three swine strains isolated in Japan (GenBank accession numbers AB471981.1, AB471980.1, and AB292650.1). Similar results were obtained for pig livers in Germany, 42 where 4% of the samples tested were found to be positive for HEV. Sequence determination and phylogenetic analysis classified the isolate strains as HEV genotype 3. In Italy, HEV RNA was detected in 31 out of 48 pigs (64.6%). 43 The virus was found at a statistically higher rate in the 3-to 4-month-old pigs (95.0%) than in the 9-to 10-month-old ones (42.9%). According to the nucleotide sequence phylogenetic tree of the ORF2 region (341 nucleotides) of the other isolated strain roFPR4, it was very closely related, presenting a maximum identity of 97% with a human isolate from the Netherlands (GenBank accession number JQ929109) and an identity of 93% with one human isolate from Hungary (GenBank accession number EF530667). The sequence identity of the analysed ORF2 fragment within the roFPR4 and the other strains from GenBank was in the range of 91-97%. Because of the lack of published studies describing human HEV circulation in Romania, we used human and swine HEV isolated in neighbouring European countries in our phylogenetic analysis.
In the Netherlands, different swine HEV strains were characterized and typed as genotype 3, showing close genetic similarity to European human strains. 44 The same results were obtained in
France after comparing the genetic identity of HEV strains found in humans and in swine. 45 Our results confirm that domestic pigs may represent an important animal reservoir of HEV infection. Intensive pig farming may have become the major amplifier of the virus. In our study, we found positive pooled faecal samples for HEV RNA at each farm. Positive samples were detected in young pigs aged 2.5-4 months.
In conclusion, the prevalence of HEV in humans in Romania is comparable to that in other European countries. The detection of HEV RNA in pooled faecal samples indicates the presence of HEV in pig farms, and swine are considered a reservoir for HEV infection in humans. The detection of swine positive for HEV raises concerns about the potential zoonotic transmission of this virus, either through exposure to the environment or by consumption of contaminated pork products.
